Filing metadata

Accession number
0001209191-22-020519
Form type
Form 4
Filer
Inozyme Pharma, Inc.
CIK
CIK 1693011
Filed
Mar 22, 2022
Reporting period
Mar 21, 2022
Description
Insider transaction

Explore SEC Filings Hub